Ionis Pharmaceuticals IONS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $246.09M+87.0% | $203.33M-10.3% | $156.72M+17.1% | $452.05M+101% | $131.61M+10.1% | ||
| $2.98M+104% | $7.96M+108% | $2.34M+118% | $4.15M-0.3% | $1.46M-32.0% | ||
| $243.11M+86.8% | $195.37M-12.3% | $154.38M+16.3% | $447.9M+103% | $130.15M+10.9% | ||
| 98.8%-0.1pp | 96.1%-2.2pp | 98.5%-0.7pp | 99.1%+0.9pp | 98.9%+0.7pp | ||
| —— | $228.9M+1.6% | $228.9M+1.6% | $228.9M+1.6% | $228.9M+1.6% | ||
| $150.36M+97.2% | $130.19M+47.8% | $96.81M+57.1% | $90.62M+39.2% | $76.25M+44.8% | ||
| $363.52M+30.5% | $417.79M+23.8% | $316.9M+12.2% | $312.23M+7.2% | $278.47M+3.5% | ||
| -$117.42M+20.0% | -$214.46M-93.5% | -$160.18M-7.8% | $139.82M+312% | -$146.86M+1.8% | ||
| -47.7%+63.9pp | -105.5%-56.6pp | -102.2%+8.9pp | 30.9%+60.3pp | -111.6%+13.5pp | ||
| $5.16M+25.6% | $4.83M+15.2% | $4.21M+1.2% | $4.11M-8.4% | $4.11M-1.0% | ||
| -$456K-198% | -$16.29M-5,493% | $363K+156% | $102K-83.3% | $465K+67.9% | ||
| -$92.31M+37.1% | -$227.92M-113% | -$128.39M+10.9% | $123.53M+287% | -$146.82M-2.9% | ||
| $218K+87.9% | $1.48M+155% | $213K+106% | -$20K-131% | $116K+54.7% | ||
| -$92.53M+37.0% | -$229.39M-120% | -$128.61M+8.5% | $123.55M+286% | -$146.94M-2.9% | ||
| -37.6%+74.0pp | -112.8%-66.8pp | -82.1%+22.9pp | 27.3%+56.7pp | -111.6%+7.9pp | ||
| -$0.56+39.8% | -$1.41-114% | -$0.80+15.8% | $0.70+256% | -$0.93+5.1% | ||
| -$113.46M+21.2% | -$210.56M-94.7% | -$157.31M-8.0% | $142.68M+326% | -$144.05M+1.6% | ||
| -46.1%+63.3pp | -103.6%-55.8pp | -100.4%+8.5pp | 31.6%+59.5pp | -109.5%+13.0pp | ||
| -$117.42M+20.0% | -$214.46M-93.5% | -$160.18M-7.8% | $139.82M+312% | -$146.86M+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ionis Pharmaceuticals's revenue?
- Ionis Pharmaceuticals (IONS) generated $1.1B in revenue over the trailing twelve months, up 47.5% year over year.
- Is Ionis Pharmaceuticals profitable?
- Ionis Pharmaceuticals is not currently profitable: it reported a net loss of $327.0M over the trailing twelve months, a -30.9% net margin.
- What are Ionis Pharmaceuticals's profit margins?
- Gross margin is 98.4% and operating margin is -33.3%, with a -30.9% net margin.
- What is Ionis Pharmaceuticals's earnings per share?
- Ionis Pharmaceuticals's diluted EPS over the trailing twelve months is $-2.07.
- Where does Ionis Pharmaceuticals's income statement data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
